Vanguard Health Care Fund Comments on Amgen Inc

Author's Avatar
Mar 27, 2015

We trimmed our position in Amgen (AMGN), a U.S.-based global biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. The stock was a strong performer in the latter half of 2014 given restructuring efforts to focus more attention on research and development.

From Vanguard Health Care Fund (Trades, Portfolio) 2014 Annual Report